Your search matched 16 results
AI is to 2019 what blockchain was to 2018.
There’s a lot to be learned from Boeing’s reputational challenges – and their early efforts to start rebuilding trust among pilots, flight attendants and customers.
The Institute for Clinical and Economic Review (ICER) has gained industry-wide notoriety for their cost effectiveness analyses, which typically investigate the value of available treatments within a specific disease state.
Prescription delivery services – like Hims, Roman and Kick – are popping up all over the place, prompting concerns about regulation.
You may have seen a lot of recent reporting on “loss of coverage” for Americans.
The Week That Was: I do, Ms. | Blog
The Center for Medicare and Medicaid Services (CMS) finalized a rule for covering CAR-T therapies and not everyone is jumping for joy.
What do CBD, digital health and “femtech” all have in common?
The anti-vaccination movement is causing challenges not just in healthcare, but now in tech.
Do you love that LaLa feeling?
Employers wield enormous influence in deciding the care their employees receive – yet they aren’t always considered a core “stakeholder” in the healthcare debate.
As the industry awaits a potential executive order on transparency around healthcare costs, we took a look at some transparency tools, and where they’re falling short.
In case you haven’t heard, it’s the New Year.
As digital health continues to grow in prevalence, so do patient information databases.
Everyone seems to be talking about digital health, but what does that really look like in action?
Drug makers aren’t the only ones under pressure for high costs.
Headlines about the Senate Finance Committee’s bill are everywhere.